Commense Company Profile

08:16 EDT 1st October 2016 | BioPortfolio

News Articles [6 Associated News Articles listed on BioPortfolio]

New PureTech Startup Commense Aims to Protect Babies From Disease

Boston company creator PureTech Health already has one microbiome startup in its portfolio, Vedanta Biosciences. Today it’s unveiled a second one, Commense, with a different plan to harness the powe...

PureTech-backed Commense studying infant microbiota

PureTech Health plc (LSE:PRTC) unveiled newco Commense Inc., which aims to develop therapeutic cocktails based on microbe combinations normally transferred to newborns through the birth canal to preve...

New York University, Commense deal

Startup Licenses ?Vaginal Seeding? Approach

Boston-based Commense plans to develop microbial and nonmicrobial interventions aimed at improving child health.

East Coast Biotech Roundup: NY Disruptors, Commense, Regeneron, & More

Our East Coast drive started in New York this week, where we took a close look at the state of the city’s biotech ecosystem and the road ahead through the eyes of some of the area’s scientific ent...

Commense Advances Microbiome Platform Targeting Early Childhood Health

Founding scientists and advisors named and exclusive worldwide license obtained to prevent and treat disease through microbiome-based interventions in early childhood C...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


More Information about "Commense" on BioPortfolio

We have published hundreds of Commense news stories on BioPortfolio along with dozens of Commense Clinical Trials and PubMed Articles about Commense for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Commense Companies in our database. You can also find out about relevant Commense Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record